Idiopathic Epiretinal Membrane Surgery in Patients Aged Over 80 Years: Efficacy and Safety.

complication elderly idiopathic epiretinal membrane pars plana vitrectomy safety

Journal

Clinical ophthalmology (Auckland, N.Z.)
ISSN: 1177-5467
Titre abrégé: Clin Ophthalmol
Pays: New Zealand
ID NLM: 101321512

Informations de publication

Date de publication:
2023
Historique:
received: 30 08 2023
accepted: 27 10 2023
medline: 9 11 2023
pubmed: 9 11 2023
entrez: 9 11 2023
Statut: epublish

Résumé

To evaluate the efficacy and safety of idiopathic epiretinal membrane (ERM) surgery in patients aged over 80 years. Consecutive patients who underwent pars plana vitrectomy (PPV) combined with ERM and internal limiting membrane (ILM) peeling with retrobulbar anesthesia were recruited. Based on age, the patients were divided into the elderly group (≥ 80 years of age) and the control group (< 80 years of age). The best-corrected visual acuity (BCVA) and surgical complications were regarded as the main measurement indicators. This study included 43 eyes from 43 patients aged 80 to 91 years and 86 eyes from 86 patients aged 54 to 79 years. Surgical intervention substantially improved BCVA both in the elderly and control groups (p = 0.005 and p < 0.001, respectively). Statistical analyses showed no significant difference in the incidence of surgical complications between the two groups (p = 0.631). The operations in either group were not delayed or canceled for the reason of complications of retrobulbar anesthesia, severe anxiety, or physical discomfort in the perioperative period. Moreover, no patient required a second operation. Also, no stroke, myocardial infarction, or death occurred during the follow-up period. All the surgical complications were treated satisfactorily. Our outcomes indicate that PPV combined with ERM and ILM peeling with retrobulbar anesthesia is effective and safe in elderly patients aged 80 years or older. Based on age alone, we believe that advancing age should not be the risk factor for idiopathic ERM surgery.

Identifiants

pubmed: 37941775
doi: 10.2147/OPTH.S437815
pii: 437815
pmc: PMC10629405
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3365-3372

Informations de copyright

© 2023 Li et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests in this work.

Références

Eye (Lond). 2013 May;27(5):644-51
pubmed: 23449509
BMJ Open. 2023 Feb 22;13(2):e065902
pubmed: 36813502
BMC Ophthalmol. 2020 Mar 10;20(1):95
pubmed: 32156267
Semin Ophthalmol. 2001 Sep;16(3):151-7
pubmed: 15513434
ANZ J Surg. 2002 Aug;72(8):537-41
pubmed: 12190721
Am J Ophthalmol. 2010 Feb;149(2):302-6
pubmed: 20103056
BMC Cancer. 2005 Dec 02;5:153
pubmed: 16324216
Curr Eye Res. 2012 Jan;37(1):50-4
pubmed: 21988485
Clin Exp Ophthalmol. 2005 Aug;33(4):373-8
pubmed: 16033349
Transl Vis Sci Technol. 2021 Feb 5;10(2):36
pubmed: 34003921
CMAJ. 2001 Sep 18;165(6):759-64
pubmed: 11584563
BMC Ophthalmol. 2022 Jan 20;22(1):30
pubmed: 35057773
Sci Rep. 2019 Dec 13;9(1):19056
pubmed: 31836768
Ophthalmology. 2014 Jan;121(1):311-317
pubmed: 23870800
J Am Geriatr Soc. 2005 Mar;53(3):424-9
pubmed: 15743284
Cancer Med. 2016 Jun;5(6):1047-54
pubmed: 26923309
Curr Eye Res. 2020 Jun;45(6):733-736
pubmed: 31747306
Mater Today Bio. 2023 Feb 14;19:100568
pubmed: 36846307
Cochrane Database Syst Rev. 2021 Mar 24;3:CD013297
pubmed: 33760235
Euro Surveill. 2023 Mar;28(9):
pubmed: 36862096
BMC Cancer. 2019 Nov 6;19(1):946
pubmed: 31690275
Ann Thorac Cardiovasc Surg. 2016 Jun 20;22(3):131-8
pubmed: 26822739
Am J Surg. 2005 Nov;190(5):795-9
pubmed: 16226960
Retina. 2015 Aug;35(8):1615-21
pubmed: 25830695
Eur J Ophthalmol. 2021 Jul;31(4):2013-2019
pubmed: 32744056
Am J Ophthalmol. 2005 Aug;140(2):288-94
pubmed: 16023066
Exp Ther Med. 2019 Dec;18(6):4583-4590
pubmed: 31798698
Int Ophthalmol. 2020 Aug;40(8):2023-2029
pubmed: 32342255
Cardiol Res Pract. 2019 Dec 18;2019:1846904
pubmed: 31929898
Sci Rep. 2021 Jul 26;11(1):15171
pubmed: 34312486
Ophthalmic Surg Lasers. 1997 Jan;28(1):37-42
pubmed: 9031303
Medicine (Baltimore). 2018 Aug;97(34):e11826
pubmed: 30142773
Ophthalmology. 2017 Feb;124(2):263-267
pubmed: 27986382
Ophthalmology. 2010 Oct;117(10):1894-9, 1899.e1
pubmed: 20591488
J Am Coll Surg. 2006 Dec;203(6):865-77
pubmed: 17116555
Curr Opin Anaesthesiol. 2008 Jun;21(3):375-9
pubmed: 18458558
Transl Lung Cancer Res. 2022 Dec;11(12):2382-2394
pubmed: 36636423
J Ophthalmol. 2018 May 13;2018:6543937
pubmed: 29862066

Auteurs

Qingjian Li (Q)

Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

Kunhuan Yang (K)

Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian, People's Republic of China.
Fujian Engineering and Research Center of Eye Regenerative Medicine, Xiamen, Fujian, People's Republic of China.
Eye Institute of Xiamen University, Xiamen, Fujian, People's Republic of China.
Xiamen University School of Medicine, Xiamen, Fujian, People's Republic of China.

Qianlin Ji (Q)

Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

Jing Jiang (J)

Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

Rongrong Zong (R)

Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian, People's Republic of China.
Fujian Engineering and Research Center of Eye Regenerative Medicine, Xiamen, Fujian, People's Republic of China.
Eye Institute of Xiamen University, Xiamen, Fujian, People's Republic of China.
Xiamen University School of Medicine, Xiamen, Fujian, People's Republic of China.

Yu Zhang (Y)

Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

Yiwen Qian (Y)

Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

Xin Che (X)

Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

Jinshan Suo (J)

Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

Zhiliang Wang (Z)

Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

Classifications MeSH